Belite Bio (BLTE) Tops Q1 EPS by 10c

Belite Bio (NASDAQ: BLTE) reported Q1 EPS of ($0.27), $0.10 better than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Belite Bio (BLTE) click here.

You May Also Be Interested In

• LeonaBio (LONA) Reiterated at Market Outperform by Citizens on Pipeline Development
• Deutsche Bank Upgrades PennyMac Mortgage Investment Trust (PMT) to Buy
• ICICI Securities Starts Cemindia Projects (CEMPRO:IN) at Buy (1)